IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba

scientific article

IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JMV.20080
P698PubMed publication ID15122797
P5875ResearchGate publication ID8582293

P50authorThomas DennyQ42939171
Mayling AlvarezQ117750898
P2093author name stringMaría G Guzmán
Susana Vázquez
Beatriz Sierra
Ana B Pérez
Delfina Rosario
Rosmary Rodríguez
Gissel García
Eric Martínez
María V Cabrera
P2860cites workSuppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virusQ27472728
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic feverQ29619585
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infectionsQ33342343
Immunopathogenesis of Dengue hemorrhagic feverQ33597146
Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at largeQ34394784
Epidemiologic studies on Dengue in Santiago de Cuba, 1997.Q39038290
Fatal dengue hemorrhagic fever in Cuba, 1997.Q39038297
Why dengue haemorrhagic fever in Cuba? 2. An integral analysisQ39146775
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic feverQ40631748
IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE)Q58831703
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectCubaQ241
epidemiologyQ133805
patientQ181600
Dengue virusQ476209
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)230-234
P577publication date2004-06-01
P1433published inJournal of Medical VirologyQ15716684
P1476titleIL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba
P478volume73

Reverse relations

cites work (P2860)
Q35716620A three-component biomarker panel for prediction of dengue hemorrhagic fever.
Q35484895Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice
Q34353489An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.
Q34550268Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.
Q40341836Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection
Q34500247Cellular and cytokine correlates of severe dengue infection
Q92257420Characterization of Biomarker Levels in Crimean-Congo Hemorrhagic Fever and Hantavirus Fever with Renal Syndrome
Q36523226Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor
Q33414050Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia
Q90443656Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017
Q35551374Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans
Q36085940Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials
Q34533363Cytokine expression profile of dengue patients at different phases of illness.
Q27469822Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection
Q34463249Dengue NS1 antigen as a marker of severe clinical disease
Q37633158Dengue in Cuba: research strategy to support dengue control
Q24645380Dengue virus pathogenesis: an integrated view
Q27026302Dengue viruses - an overview
Q34088164Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus
Q40440415Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency
Q34178965Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever
Q27481682High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection
Q33419779High producing tumor necrosis factor alpha gene alleles in protection against severe manifestations of dengue
Q27487567IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
Q33430763Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity
Q35935142Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype
Q40040257Indices of anti-Dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase
Q33962671Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever.
Q27315772Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification
Q38704501Macrophage Activation Syndrome-Associated Markers in Severe Dengue
Q36305184Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengue
Q41722923Meta-analysis of biomarkers for severe dengue infections.
Q34746720Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease
Q54217627Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Q36666340Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).
Q27312219Patterns and causes of liver involvement in acute dengue infection
Q36720238Primary dengue virus infections induce differential cytokine production in Mexican patients.
Q35009119Progress towards a dengue vaccine
Q34222029RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.
Q27477646Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
Q39187784Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design
Q38174301Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology
Q90403030Role of Interleukin-10 and Abdominopelvic Ultrasound as a Potential Predictor of Disease Severity in Dengue Hemorrhagic Fever
Q34862804Serum IL-10 as a marker of severe dengue infection
Q28551236Serum Metabolomics Reveals Serotonin as a Predictor of Severe Dengue in the Early Phase of Dengue Fever
Q40161217Serum levels of IL-8, IFNγ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection
Q34500818Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF.
Q36978907The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability
Q58582556The monocyte-macrophage-mast cell axis in dengue pathogenesis
Q37904027The pathogenesis of dengue
Q27490496The relationship of interacting immunological components in dengue pathogenesis
Q36576509The two faces of interleukin 10 in human infectious diseases
Q27480996Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1
Q40167695Vascular leakage in dengue hemorrhagic Fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production

Search more.